Copyright
©The Author(s) 2021.
World J Clin Cases. Oct 16, 2021; 9(29): 8694-8701
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8694
Published online Oct 16, 2021. doi: 10.12998/wjcc.v9.i29.8694
Table 2 Comparison of therapeutic effects between the two groups, n (%)
| Group | n | Remarkably effective | Effective | Invalid | Total effectiveness |
| Study | 37 | 23 (62.16) | 12 (32.43) | 2 (5.41) | 35 (94.59) |
| Control | 37 | 17 (45.95) | 11 (29.73) | 9 (24.32) | 28 (75.68) |
| χ2 | 5.232 | ||||
| P value | 0.022 |
- Citation: Wang XX, Ma CT, Jiang YX, Ge YJ, Liu FY, Xu WG. Cefoperazone sodium/sulbactam sodium vs piperacillin sodium/tazobactam sodium for treatment of respiratory tract infection in elderly patients. World J Clin Cases 2021; 9(29): 8694-8701
- URL: https://www.wjgnet.com/2307-8960/full/v9/i29/8694.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i29.8694